These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8962137)

  • 21. Sorting and secretion of a melanosome membrane protein, gp75/TRP1.
    Xu Y; Setaluri V; Takechi Y; Houghton AN
    J Invest Dermatol; 1997 Dec; 109(6):788-95. PubMed ID: 9406822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems.
    Gregor PD; Wolchok JD; Ferrone CR; Buchinshky H; Guevara-Patiño JA; Perales MA; Mortazavi F; Bacich D; Heston W; Latouche JB; Sadelain M; Allison JP; Scher HI; Houghton AN
    Vaccine; 2004 Apr; 22(13-14):1700-8. PubMed ID: 15068853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance.
    Yu Z; Theoret MR; Touloukian CE; Surman DR; Garman SC; Feigenbaum L; Baxter TK; Baker BM; Restifo NP
    J Clin Invest; 2004 Aug; 114(4):551-9. PubMed ID: 15314692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
    Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
    J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of heat-stable antigen on tumor cells provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice.
    Wang YC; Zhu L; McHugh R; Sell KW; Selvaraj P
    Eur J Immunol; 1995 May; 25(5):1163-7. PubMed ID: 7774619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple pathways to tumor immunity and concomitant autoimmunity.
    Turk MJ; Wolchok JD; Guevara-Patino JA; Goldberg SM; Houghton AN
    Immunol Rev; 2002 Oct; 188():122-35. PubMed ID: 12445286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response.
    Ji Q; Gondek D; Hurwitz AA
    J Immunol; 2005 Aug; 175(3):1456-63. PubMed ID: 16034082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of autoantigens by patients with melanoma.
    Houghton AN; Vijayasaradhi S; Bouchard B; Naftzger C; Hara I; Chapman PB
    Ann N Y Acad Sci; 1993 Aug; 690():59-68. PubMed ID: 8368771
    [No Abstract]   [Full Text] [Related]  

  • 29. Autoimmune depigmentation following sensitization to melanoma antigens.
    Hurwitz AA; Ji Q
    Methods Mol Med; 2004; 102():421-7. PubMed ID: 15286398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunity to cancer through immune recognition of altered self: studies with melanoma.
    Guevara-Patiño JA; Turk MJ; Wolchok JD; Houghton AN
    Adv Cancer Res; 2003; 90():157-77. PubMed ID: 14710950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
    Chen YT; Stockert E; Tsang S; Coplan KA; Old LJ
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8125-9. PubMed ID: 7667256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanoma progression despite infiltration by in vivo-primed TRP-2-specific T cells.
    Singh V; Ji Q; Feigenbaum L; Leighty RM; Hurwitz AA
    J Immunother; 2009; 32(2):129-39. PubMed ID: 19238011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
    Saenger YM; Li Y; Chiou KC; Chan B; Rizzuto G; Terzulli SL; Merghoub T; Houghton AN; Wolchok JD
    Cancer Res; 2008 Dec; 68(23):9884-91. PubMed ID: 19047169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen.
    Gold JS; Ferrone CR; Guevara-Patiño JA; Hawkins WG; Dyall R; Engelhorn ME; Wolchok JD; Lewis JJ; Houghton AN
    J Immunol; 2003 May; 170(10):5188-94. PubMed ID: 12734366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.
    van Elsas A; Hurwitz AA; Allison JP
    J Exp Med; 1999 Aug; 190(3):355-66. PubMed ID: 10430624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1.
    Rausch MP; Irvine KR; Antony PA; Restifo NP; Cresswell P; Hastings KT
    J Immunol; 2010 Sep; 185(5):2828-35. PubMed ID: 20668223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo.
    Bronte V; Apolloni E; Ronca R; Zamboni P; Overwijk WW; Surman DR; Restifo NP; Zanovello P
    Cancer Res; 2000 Jan; 60(2):253-8. PubMed ID: 10667570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma.
    Bellone M; Cantarella D; Castiglioni P; Crosti MC; Ronchetti A; Moro M; Garancini MP; Casorati G; Dellabona P
    J Immunol; 2000 Sep; 165(5):2651-6. PubMed ID: 10946294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity.
    Hawkins WG; Gold JS; Dyall R; Wolchok JD; Hoos A; Bowne WB; Srinivasan R; Houghton AN; Lewis JJ
    Surgery; 2000 Aug; 128(2):273-80. PubMed ID: 10923004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLR7 stimulation augments T effector-mediated rejection of skin expressing neo-self antigen in keratinocytes.
    Zhong J; Hadis U; De Kluyver R; Leggatt GR; Fernando GJ; Frazer IH
    Eur J Immunol; 2008 Jan; 38(1):73-81. PubMed ID: 18157820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.